Erwinia Chrysanthemi asparaginase
15-107
Phase 1 small_molecule terminated
Quick answer
Erwinia Chrysanthemi asparaginase for Acute Lymphoblastic Leukemia (ALL) is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Acute Lymphoblastic Leukemia (ALL)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated